Estrogenic activities of compound GL-1, isolated from Ganoderma lucidum

Abstract In this study, the estrogenic effect of GL-1, a component of the Ganoderma lucidum, was studied, and the possible mechanism was discussed preliminarily. The binding ability of GL-1 to estrogen receptor was calculated by computer aided simulation. The effects of GL-1 on the proliferation of estrogen sensitive estrogen receptor (ER) (+) MCF-7 cells and estrogen insensitive ER (−) MDA-MB-231 cells were detected by MTT method. The effects of GL-1 on the proliferation of estrogen-induced MCF-7 cells, and the effects of the estrogen receptor inhibitor ICI182780 on the proliferation of GL-1-induced MCF-7 cells were detected by MTT assay. The expression of ERα and ERβ monoclonal antibody were detected by Western blot. The results showed that GL-1 has a good binding ability to estrogen receptor β, and has estrogen-like effect, which might be related to secretion of estrogen and expression of ERβ by binding to ERs.

[1]  Burton B. Yang,et al.  Ganoderma lucidum spore oil induces apoptosis of breast cancer cells in vitro and in vivo by activating caspase-3 and caspase-9. , 2020, Journal of ethnopharmacology.

[2]  S. Suh,et al.  Antiinflammatory lanostane triterpenoids from Ganoderma lucidum , 2019, Natural product research.

[3]  Tao Wu,et al.  Bilberry anthocyanin improves the serum cholesterol in aging perimenopausal rats via the estrogen receptor signaling pathway. , 2019, Food & function.

[4]  Ge Liu,et al.  The natural compound GL22, isolated from Ganoderma mushrooms, suppresses tumor growth by altering lipid metabolism and triggering cell death , 2018, Cell Death & Disease.

[5]  Haiping Zhao,et al.  Emerging Roles of Ganoderma Lucidum in Anti-Aging , 2017, Aging and disease.

[6]  Kun Ma,et al.  [Application of kidney deficiency and blood stasis and disharmony between heart and kidney theories in patients with sleep disorders in perimenopause]. , 2017, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[7]  D. Ojcius,et al.  Corrigendum: Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota , 2017, Nature Communications.

[8]  Hua-Jun Luo,et al.  A novel class of α-glucosidase and HMG-CoA reductase inhibitors from Ganoderma leucocontextum and the anti-diabetic properties of ganomycin I in KK-Ay mice. , 2017, European journal of medicinal chemistry.

[9]  Rosanna Manco,et al.  Structural data and immunomodulatory properties of a water-soluble heteroglycan extracted from the mycelium of an Italian isolate of Ganoderma lucidum , 2017, Natural product research.

[10]  Hongwei Liu,et al.  Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase. , 2015, Journal of natural products.

[11]  Z. Pan,et al.  Estrogen receptor-beta agonist diarylpropionitrile counteracts the estrogenic activity of estrogen receptor-alpha agonist propylpyrazole-triol in the mammary gland of ovariectomized Sprague Dawley rats , 2012, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  K. Kersse,et al.  Caspase-3 and caspase-7 , 2013 .

[13]  G. C. Chan,et al.  Ganoderma lucidum (Reishi mushroom) for cancer treatment. , 2012, The Cochrane database of systematic reviews.